Biotech Values

[alertmeipp]

At this price, I wish ENTA could just start a formal strategic review and shop itself to the highest bidder. There is clearly some trust issues with the management from the market, the market is assigning less and less value to its pipeline as they make progress.

The crazy thing is if they conclude it this year, worst case we probably get a 3x return from here. Best case, a lot higher.

Maybe I should try to get a hold of management and suggest that. ;)